KIDNEY
TUMORS
Pathology
RENAL TUMORS
Benign tumour
•1.Angiomyolipoma
•2.Oncocytoma
•3.Renal papillary
adenoma
Malignant tumour
•1. Renal cell
carcinoma
•2. Wilms tumour
BENIGN TUMORS
qNon-cancerous growths of the kidney that do
not metastasize to other sides of the body.
qNot life threatening but can cause complaints if
they exert pressure
ANGIOMYOLIPOMA
q Consists of vessels , smooth muscles and fat
q Originates from perivascular epithelioid cells
q Present in 25-50% of patients with tuberous sclerosis
q Caused by loss of function mutation in TSC1 or TSC2 (TSG)
q Tuberous sclerosis is characterised by -
q Lesions of cerebral cortex that produce epilepsy and mental
retardation
q Skin abnormalities
q Clinical importance = Susceptibility to spontaneous
haemorrhage.
ONCOCYTOMA
q Epithelial neoplasm
q Composed of large eosinophilic cells having
q Small
q Round
q benign
appearing nuclei that have large nucleoli.
q Arises from intercalated cells of collecting ducts.
GROSS APPEARANCE:
q Tumors are tan or
Mahogany Brown.
q Relatively homogenous
q Usually well encapsulated
with central scar
H/E
q Polygonal cells with
abundant eosinophilic
granular cytoplasm
q Excess of mitochondria
RENAL
PAPILLARY
ADENOMA
qVery rare
qPresents as a
yellow plaque
qPapillary
configuration on
microscopy
MALIGNANT TUMORS
RENAL CELL
CARCINOMA
INTRODUCTION
•More often in older
individuals (6th and 7th
decades of life)
•2:1 male
preponderance
•a/k/a
•Grawitz tumor
•Adenocarcinoma
•Hypernephroma
RISK FACTORS
Tobacco Obesity Hypertension
Asbestos,
petroleum
products,
heavy metals
End stage
renal disease
Chronic
kidney
disease
Acquired
cystic disease
Tuberous
sclerosis
GENETICS OF RCC
1. VHL gene on chr 3p
•Autosomal dominant
•Risk of clear cell cancer
2. HLRCC
•Hereditary
leiomyomatosis
•Mutation in fumarate
hydratase gene
•Risk of papillary cell
carcinoma
3. HPRCC
•Hereditary
papillary RCC
•Mutation in
MET gene
•Hepatocyte
growth factor
increased
expression
4. Birt Hogg
Dube syndrome
•Due to
mutation in
BHD gene
•Encodes for
folliculin
•Increase risk
of
chromophobe
cancer
5. Other
•Hypodiploidy
•Loss of y-
chromosome
•Trisomy 7, 17
PARANEOPLASTIC SYNDROME
Increase
ESR
Anemia
Polycythaemia Leukemoid
reaction
Non
metastatic
hepatic
dysfunction
Amyloido
sis
Increase in
calcium ions
feminisation/
masculanizati
on
Cushing
syndrome
TYPES OF RCC
BASED ON- CORRELATIVE CYTOGENETIC, GENETIC AND HISTOLOGIC STUDIES-
q Clear cell RCC
q Papillary RCC
q Chromophobe RCC
q Collecting duct
q XP 11 translocation carcinoma
COLLECTING DUCT CARCINOMA
WILMS
TUMOR
q Age - 2-5 years
q a/k/a Neuroblastoma
q Genetic-
q Loss of function mutation in-
§ WT1 on ch. 11p13
§ WT2 on ch. 11p15
q Presence of anaplasia - mutation of
tp53 mutation
q emergence of risk to chemotherapy
(unresponsiveness of anaplastic cells
to cytotoxic chemotherapy)
MORPHOLOGY
q Large solitary well
circumscribed mass
q Soft homogenous tan to grey
with occasional foci of
hemorrhage cyst formation
and necrosis
TRIPHASIC
COMBINATION-
MICROSCOPY
Blastemal cells
Stromal cells
Epithelial cells
CLINICAL
FEATURES
qLarge abdominal mass
qHaematuria
qPain in abdomen after traumatic
incidence
qIntestinal obstruction
qAppearance of hypertension
CASE: A 15 YEAR OLD GIRL
WITH SICKLE CELL TRAIT
PRESENTED WITH GROSS
HEMATURIA, FLANK PAIN
AND LYMPHADENOPATHY.
SHE IS DIAGNOSED AS A
CASE OF RCC. NAME THE
TYPE OF RCC SHE IS LIKELY
TO HAVE?
A. Medullary
B. Papillary
C. Chromophobe
D. Colloid
Q. ACQUIRED CYSTIC DISEASE OF
KIDNEY ASSOCIATED WITH
A. Xantho-granulomatous
Pyelonephritis
B. Dialysis
C. Renal Stones
D. Renal Dysplasia
Q. TRUE STATEMENT ABOUT
RCC
A. ASBESTOS, SICKLE CELL
ANEMIA & PETROLEUM
PRODUCTS ARE RISK
FACTORS
B. CLEAR CELL CANCER ARISE
FROM PCT
C. CANNON BALL METASTASIS
D. BELLINI DUCT ARISE FROM
FROM LOOP OF HENLE
1. A,B,D are true
2. A,C,D are true
3. Only A & D are true
4. A,B,C are true
Q. IN WHICH OF THE
FOLLOWING
CONDITION
,ANIRIDIA AND
HEMI-
HYPERTROPHY ARE
MOST LIKELY TO
PRESENT ?
A. Neuroblastoma
B. Wilm’s Tumor
C. Non- Hogkin Lymphoma
D. Germ Cell Tumor
THANK YOU

Kidney tumors